Stock News
Novavax’s Future Hinges On Sanofi Deal And Upcoming Milestones (NASDAQ:NVAX)
Kelvin Murray Introduction Novavax’s (NASDAQ:NVAX) stock is up almost 40% since my rating upgrade to “hold” in May. The upgrade followed a collaboration with Sanofi (SNY), granting the pharma giant a license for Novavax’s adjuvanted […]